Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iridium Netwerk is a Belgian radiotherapy care network focused on highly specialized radiation oncology services for patients with cancer. Formerly known as Iridium Kankernetwerk, the organization narrowed its focus to radiotherapy and now operates as the largest radiotherapy network in Belgium, coordinating care across eight partner hospitals in and around Antwerp. Its activities center on multidisciplinary patient care, radiotherapy treatment delivery, oncology support services, and translational and clinical research in radiation oncology. The network also collaborates with academic and technology partners to modernize workflow, imaging, treatment planning, and quality management in radiotherapy. Iridium is not a drug-development biotech or pharma company; it is a mature healthcare delivery organization with active clinical operations and research programs in radiation oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iridium Netwerk.